SGRY
Surgery Partners·NASDAQ
--
--(--)
--
--(--)
5.05 / 10
Netural
Capital flows are robust (fund flow score 7.9/10), with positive trends in overall, block, and extra-large inflows, despite some smaller-scale outflows. Analyst sentiment is overwhelmingly bullish with a 100% Buy rating from one active analyst, yet the sparse coverage limits conviction. Overall, the stock shows healthy fund inflows and supportive analyst views, complementing its solid fundamentals.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-18
InstitutionMizuho
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for SGRY?
- SGRY holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.05/10 (Netural).
